Medicine Description adricin 10 mg
Adricin 10 mg/5ml i.v. vial is a sterile injectable formulation manufactured by Hikma, containing doxorubicin as its active ingredient. Doxorubicin works by interfering with the DNA replication process in cancer cells, inhibiting their growth and proliferation. This makes Adricin effective in the treatment of various malignancies.
Indications and Uses of Adricin 10 mg/5ml i.v. vial
- Treatment of breast cancer
- Treatment of ovarian cancer
- Treatment of lung cancer
- Treatment of bladder cancer
- Treatment of leukemia
- Treatment of lymphoma
How to Use Adricin 10 mg/5ml i.v. vial
- Administer the solution intravenously as directed by the doctor or pharmacist.
- Ensure proper dilution if required before administration.
- Monitor for any adverse reactions during the infusion.
- Follow aseptic techniques during preparation and administration.
- Avoid extravasation during injection to prevent tissue damage.
Contraindications of Adricin 10 mg/5ml i.v. vial
- Hypersensitivity to doxorubicin or any of its components
- Severe liver impairment
- Recent vaccination with live vaccines
- Pregnancy
- Severe myelosuppression
Drug Interactions
- May interact with other chemotherapy agents
- Potential interactions with anticoagulants
- Caution with drugs affecting liver enzymes
- Avoid concomitant use with live vaccines
- Empty array
Side Effects of Adricin 10 mg/5ml i.v. vial
- Nausea and vomiting
- Hair loss
- Fatigue
- Mouth sores
- Low blood cell counts
- Cardiac toxicity
Storage and Handling
Store at controlled room temperature, protected from light. Keep out of reach of children and discard any unused portion after opening.
Warnings and Precautions
Patients should avoid driving if they experience drowsiness. Pregnant or breastfeeding women should discuss the risks with their healthcare provider. Special care is needed for elderly patients and those with pre-existing health conditions. Seek immediate medical help if any severe side effects occur.